In line with a role of PTBP1 in CD19 mis-splicing in tumours, we find that patient samples from the TARGET B-ALL cohort on average show lower PTBP1 mRNA expression compared to healthy B cells (Supplementary Fig. 8a). This evidence concerns the gene CD19 and neoplasm.